Ipilimumab vs Rabeprazole
Ipilimumab vs Rabeprazole: Overview
This comparison examines the pharmacological differences between Ipilimumab and Rabeprazole.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Rabeprazole β 1-2 hours.
Chemical Properties
Molecular Formula: Rabeprazole β C18H21N3O3S.
Molecular Weight: Rabeprazole β 359.4440 g/mol.
Type: Ipilimumab β Antibody; Rabeprazole β Small molecule.